Common use of THE FRAMEWORK AGREEMENT Clause in Contracts

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop HF, divisjon legemidler) in accordance with the Danish Public Procure- ment Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities in the t wo coun- tries; Denmark and Norway (further specified as Customers in Appendix 7 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier on an ongoing ba- sis. The Supplier shall deliver pharmaceuticals in both countries (Denmark and Norway) in accordance with the terms and conditions of the Framework Agreement and the ap- pendices, including the relevant national terms and conditions specified in Appendix 7 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e provisions of the Framework Agreement shall apply to the accepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop HF, divisjon legemidler) in accordance with the Danish Public Procure- ment Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities auth orities in the t wo two coun- tries; Denmark and Norway (further specified as Customers in Appendix 7 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier Supp lier on an ongoing ba- sis. The Supplier shall deliver pharmaceuticals in both countries (Denmark and Norway) in accordance with the terms and conditions of the Framework Agreement and the ap- pendices, including the relevant national terms and conditions specified in Appendix 7 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Post -Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e the provisions of the Framework Agreement shall apply to the accepted a ccepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop ▇▇▇▇▇▇ ▇▇▇▇- husinnkjop HF, divisjon legemidlerlegemidler and Landspítali) in accordance with the Danish Public Procure- ment Procurement Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities in the t wo three coun- tries; Denmark Denmark, Norway and Norway Iceland (further specified as Customers in Appendix 7 , 8 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier on an ongoing ba- sisongo- ing basis. The Supplier shall deliver pharmaceuticals in both all three countries (Denmark Denmark, Norway and NorwayIceland) in accordance with the terms and conditions of the Framework Agreement and the ap- pendicesappendices, including the relevant national terms and conditions specified in Appendix 7 7, 8 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 7, 8 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn draw n up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Post -Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e provisions of the Framework Agreement shall apply to the accepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop HF, divisjon legemidler) in accordance with the Danish Public Procure- ment Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities auth orities in the t wo two coun- tries; Denmark and Norway (further specified as Customers in Appendix 7 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier Suppl ier on an ongoing ba- sis. The Supplier shall deliver pharmaceuticals in both countries (Denmark and Norway) in accordance with the terms and conditions of the Framework Agreement and the ap- pendices, including the relevant national terms and conditions specified in Appendix 7 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Post -Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e provisions of the Framework Agreement shall apply to the accepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop Amgros, Syke- husinnkjop HF, divisjon legemidlerlegemidler and Landspítali) in accordance with the Danish Public Procure- ment Procurement Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities in the t wo three coun- tries; Denmark Denmark, Norway and Norway Iceland (further specified as Customers in Appendix 7 7, 8 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier on an ongoing ba- sisongo- ing basis. The Supplier shall deliver pharmaceuticals in both all three countries (Denmark ( Denmark, Norway and NorwayIceland) in accordance with the terms and conditions of the Framework Agreement and the ap- pendicesappendices, including the relevant national terms and conditions specified in Appendix 7 7, 8 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 7, 8 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Post -Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e provisions of the Framework Agreement shall apply to the accepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.

THE FRAMEWORK AGREEMENT. 1.1 This framework agreement (the "Framework Agreement") has been concluded on the basis of a joint public procurement held by the Contracting Authorities (Amgros and Sykehusinnkjop ▇▇▇▇▇▇, Syke- husinnkjop HF, divisjon legemidlerlegemidler and Landspítali) in accordance with the Danish Public Procure- ment Procurement Act (Udbudsloven). 1.2 The purpose of the Framework Agreement is to ensure the supply of the pharmaceuti- cals listed in Appendix 1 to the public hospitals and health authorities in the t wo three coun- tries; Denmark Denmark, Norway and Norway Iceland (further specified as Customers in Appendix 7 7, 8 and 9). The Framework Agreement gives the Contracting Authorities and the Customers the right, but not the obligation, to purchase pharmaceuticals from the Supplier on an ongoing ba- sisongo- ing basis. The Supplier shall deliver pharmaceuticals in both all three countries (Denmark ( Denmark, Norway and NorwayIceland) in accordance with the terms and conditions of the Framework Agreement and the ap- pendicesappendices, including the relevant national terms and conditions specified in Appendix 7 7, 8 and 9. 1.3 In Norway purchase of the pharmaceuticals is made through a wholesaler appointed by the Customers, see Appendix 7. 1.4 In Denmark certain pharmaceuticals is resold to the Faroe Island and Greenland, see Ap- pendix 9. 1.5 The Framework Agreement is non-exclusive. The Customers are not obliged to use the Framework Agreement. 1.5.1 The Framework Agreement is entered into on the basis of a call for tenders where agreement may have been entered into with multiple suppliers under the individual procurement numbers. Purchasing shall be in accordance with the terms and condi- tions stipulated in Appendix 5. 1.6 The Framework Agreement includes a number of appendices that are considered an in- tegral part of the Framework Agreement. In case of conflict between the provisions of the Framework Agreement and the appendices 7 7, 8 or 9, the appendices shall prevail. In case of conflict between the provisions of the Framework Agreement and the other ap- pendices, the Framework Agreement shall prevail. 1.7 The Contracting Authorities in Denmark and Norway has drawn up guidelines for day-to- day cooperation, see Appendix 7 and 9. 1.8 Option for delivery in the Pre-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from signature of the Framework Agreement until the first day of the purchase period ("the Pre-Agreement Period"), the Contracting Authority or the Cus- tomer shall be entitled to request in writing that the Supplier deliver the product in the Pre-Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Pre-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the pharmaceutical cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. 1.9 Option for delivery in the Post-Agreement Period: In the event that a Contracting Authority or a Customer should wish to purchase the product in the period from expiry/termination of the Framework Agreement and on- wards ("the Post-Agreement Period"), a Contracting Authority or a Customer shall be en- titled to request in writing that the Supplier deliver the product in the Post-Agreement Post -Agreement Period at the price stipulated in Appendix 1. Agreement on delivery shall be subject to the provisions of clause 1.10. The option for delivery in the Post-Agreement Period may only be exercised by a Con- tracting Authority or a Customer where the product cannot be purchased under an agreement in force, e.g. due to a back order or if there is no agreement covering the pharmaceutical. The Post-Agreement Period shall not exceed one year. 1.10 In the event of delivery in the Pre-Agreement Period or the Post-Agreement Period, the Supplier shall not be obliged to deliver the product pursuant to orders received. The Supplier may choose to deliver the product by accepting the order, in which case th e provisions of the Framework Agreement shall apply to the accepted order. In Denmark, such orders can be accepted by the Supplier’s wholesaler, see appendix 9.